Cerebral Biochemical Effect of Pregabalin in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cerebral Biochemical Effect of Pregabalin in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial ; volume:9 ; number:4 ; day:27 ; month:6 ; year:2018 ; pages:1591-1604 ; date:8.2018
Diabetes therapy ; 9, Heft 4 (27.6.2018), 1591-1604, 8.2018
- Creator
-
Jaeger, Mats De
- Contributor
-
Goudman, Lisa
Schuerbeek, Peter Van
Mey, Johan De
Keymeulen, Bart
Brouns, Raf
Moens, Maarten
SpringerLink (Online service)
- DOI
-
10.1007/s13300-018-0460-y
- URN
-
urn:nbn:de:101:1-2018092911460514312703
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jaeger, Mats De
- Goudman, Lisa
- Schuerbeek, Peter Van
- Mey, Johan De
- Keymeulen, Bart
- Brouns, Raf
- Moens, Maarten
- SpringerLink (Online service)
Other Objects (12)
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
Painful Peripheral Neuropathy and Cancer
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
HIV-associated painful neuropathy: where are we?
Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report
Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes
Comparison of therapeutic effects of N-Acetylcysteine with pregabalin in improving the clinical symptoms of painful diabetic neuropathy: a randomized, double-blind clinical trial
Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
Painful Peripheral Neuropathy and Cancer
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
HIV-associated painful neuropathy: where are we?
Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report
Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes
Comparison of therapeutic effects of N-Acetylcysteine with pregabalin in improving the clinical symptoms of painful diabetic neuropathy: a randomized, double-blind clinical trial
Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review
Painful Peripheral Neuropathy and Cancer
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
HIV-associated painful neuropathy: where are we?
Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy
Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report
Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes
Comparison of therapeutic effects of N-Acetylcysteine with pregabalin in improving the clinical symptoms of painful diabetic neuropathy: a randomized, double-blind clinical trial
Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy